Ekinadese Aburime
Gastroenterology · Conyers, GANPI 1265693873
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Conmed Corporation at 34.8% of the total. Reporting peaked in 2024 at $8,568 and has fallen 85.9% since, to $1,206 in 2025. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $75.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conmed Corporation$6K
- AbbVie$3K
- Boston Scientific$3K
- Olympus Corporation Of The Americas$2K
- Olympus America Inc.$580
- Cook Medical LLC$366
- plus $2K from 25 others
What the payments were for
- Consulting fees$2,36315%
- Speaking & faculty fees$1,72511%
- Travel & lodging$5,66035%
- Food & beverage$6,30239%
- Education$1601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conmed Corporation | 4 | $5,640 |
| AbbVie(2 entities) | 54 | $2,869 |
| Boston Scientific | 50 | $2,659 |
| Olympus Corporation Of The Americas | 14 | $2,339 |
| Olympus America Inc. | 10 | $580 |
| Cook Medical LLC | 9 | $366 |
| Lumendi LLC | 2 | $207 |
| Johnson & Johnson(2 entities) | 9 | $201 |
| Braintree Laboratories, Inc. | 20 | $198 |
| Amgen | 5 | $128 |
| Medtronic | 4 | $118 |
| Micro-tech Endoscopy USA, Inc. | 1 | $102 |
| Daiichi Sankyo Inc. | 4 | $92 |
| Apollo Endosurgery US Inc | 1 | $91 |
| Intercept Pharmaceuticals, Inc. | 5 | $90 |
| Nestle Healthcare Nutrition Inc. | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $65 |
| Madrigal Pharmaceuticals | 2 | $48 |
| Ambu Inc. | 2 | $47 |
| Vivus LLC | 2 | $40 |
| Merit Medical Systems Inc | 1 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Pfizer | 1 | $26 |
| Boehringer Ingelheim | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $23 |
| Endogastric Solutions, Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Organon | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSEAL$5,574
- Single Use Electrosurgical Knife KD-655$1,750
- DISPOSABLE DISTAL ATTACHMENT$1,632
- Olympus$1,632
- Olympus EMR & ESD Devices$484
- Olympus Hemostasis Devices$484
- Olympus EndoTherapy Accessories$484
- EXALT Model D$340
- DiLumen$207
- ORISE$184
- SPYGLASS$165
- APOLLO ESG System$143
- EchoTip$140
- GENERAL POLYPECTOMY$133
- Autotome RX 49$128
- NGage$112
- VISIGLIDE$112
- EXALT$109
- Creon$104
- eyeMax$102
How this compares
$16,210 in reported general payments places this provider in the 90th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 51 | $134,656 |
| ZenpepLipase/Protease/Amylase | 25 | $67,201 |
| Mesalamine | 21 | $3,127 |
| Pantoprazole Sodium | 218 | $2,237 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 31 | $1,975 |
| Colestipol Hcl | 16 | $1,288 |
| Dicyclomine Hcl | 53 | $1,116 |
| Sucralfate | 18 | $1,062 |
| Omeprazole | 44 | $527 |
| Ondansetron OdtOndansetron | 13 | $401 |
| Metronidazole | 21 | $245 |
| Famotidine | 41 | $240 |
| Doxycycline Hyclate | 15 | $147 |
| Promethazine Hcl | 15 | $132 |
| Metoclopramide Hcl | 18 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $2,869 | $134,65651 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Conyers
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Satish RaoAugusta$335K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Aja McCutchenWinder$310K
- Bruce SalzbergSuwanee$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.